119 related articles for article (PubMed ID: 3756887)
41. Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial.
Feun LG; O'Brien C; Molina E; Rodriguez M; Jeffers L; Schiff ER; Marini A; Savaraj N; Ardalan B
J Cancer Res Clin Oncol; 2003 Jan; 129(1):17-20. PubMed ID: 12618896
[TBL] [Abstract][Full Text] [Related]
42. A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer.
Muss HB; Kempf RA; Martino S; Rudnick SA; Greiner J; Cooper MR; Decker D; Grunberg SM; Jackson DV; Richards F
J Clin Oncol; 1984 Sep; 2(9):1012-6. PubMed ID: 6470752
[TBL] [Abstract][Full Text] [Related]
43. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
Sarna G; Pertcheck M; Figlin R; Ardalan B
Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
[TBL] [Abstract][Full Text] [Related]
44. Interferon alfa-2b-cyclophosphamide combination studies: in vitro and phase I-II clinical results.
Durie BG; Clouse L; Braich T; Grimm M; Robertone AB
Semin Oncol; 1986 Sep; 13(3 Suppl 2):84-8. PubMed ID: 3764444
[TBL] [Abstract][Full Text] [Related]
45. Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma.
Kardinal CG; Moertel CG; Wieand HS; Schutt AJ; O'Connell MJ; Wright K; Wiesenfeld M; Tschetter LK; Krook JE
Cancer; 1993 Apr; 71(7):2187-90. PubMed ID: 8384064
[TBL] [Abstract][Full Text] [Related]
46. Phase I study of the combination of alpha-2 interferon and cisplatinum.
Walsh C; Speyer JL; Wernz J; Hochster H; Grossberg H; Chachoua A; Molinaro P; Meyers M; Blum RH
J Biol Response Mod; 1989 Feb; 8(1):11-5. PubMed ID: 2921608
[TBL] [Abstract][Full Text] [Related]
47. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
[TBL] [Abstract][Full Text] [Related]
48. Intraperitoneal alpha interferon for ovarian cancer: a case report.
Carney-Gersten P; Moore MD; Giuffre M
Oncol Nurs Forum; 1990; 17(3):403-7. PubMed ID: 2342974
[TBL] [Abstract][Full Text] [Related]
49. Phase I evaluation of recombinant tumor necrosis factor given in combination with recombinant interferon-gamma.
Smith JW; Urba WJ; Clark JW; Longo DL; Farrell M; Creekmore SP; Conlon KC; Jaffe H; Steis RG
J Immunother (1991); 1991 Oct; 10(5):355-62. PubMed ID: 1790143
[TBL] [Abstract][Full Text] [Related]
50. Phase I-II trial of interferon-alpha 2b by continuous subcutaneous infusion over 28 days.
Dorr RT; Salmon SE; Robertone A; Bonnem E
J Interferon Res; 1988 Dec; 8(6):717-25. PubMed ID: 3230330
[TBL] [Abstract][Full Text] [Related]
51. Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.
Edmonson JH; Kovach JS; Buckner JC; Kvols LK; Hahn RG
Cancer Res; 1988 Nov; 48(22):6584-6. PubMed ID: 3141046
[TBL] [Abstract][Full Text] [Related]
52. Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.
Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
Cancer Treat Rep; 1986 May; 70(5):619-24. PubMed ID: 3518925
[TBL] [Abstract][Full Text] [Related]
53. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
[No Abstract] [Full Text] [Related]
54. The combined use of interferon and radiotherapy in cancer management.
Torrisi J; Berg C; Bonnem E; Dritschilo A
Semin Oncol; 1986 Sep; 13(3 Suppl 2):78-83. PubMed ID: 3764443
[TBL] [Abstract][Full Text] [Related]
55. Phase I study of recombinant leukocyte A human interferon combined with BCNU in selected patients with advanced cancer.
Creagan ET; Kovach JS; Long HJ; Richardson RL
J Clin Oncol; 1986 Mar; 4(3):408-13. PubMed ID: 3950678
[TBL] [Abstract][Full Text] [Related]
56. Phase I study of recombinant gamma-interferon (rIFN-gamma).
Boman BM; Gagen MM; Bonnem E; Ajani JA; Schmidt S; Dimery IW; Golando J; Neidhart J
J Biol Response Mod; 1988 Oct; 7(5):438-46. PubMed ID: 3141591
[TBL] [Abstract][Full Text] [Related]
57. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
Muss HB; Richards F; Homesley HD; Spurr CL; Rudnick SA; Stuart JJ; Plunkett S; Welander C; Caponera M; White DR
Am J Clin Oncol; 1985 Apr; 8(2):97-107. PubMed ID: 3834792
[TBL] [Abstract][Full Text] [Related]
58. [Phase II study of interferon-beta (MR-21) in solid tumors. The Cooperative Study Group of MR-21 in Tumor].
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):942-7. PubMed ID: 3694003
[No Abstract] [Full Text] [Related]
59. Phase I study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily x3 schedule.
Ratain MJ; Skoog LA; O'Brien SM; Cooper N; Schilsky RL; Vogelzang NJ; Gerber M; Narang PK; Nicol SJ
Ann Oncol; 1997 Aug; 8(8):807-9. PubMed ID: 9332692
[TBL] [Abstract][Full Text] [Related]
60. [Phase I study of interferon-beta (MR-21) in patients with malignant tumors. The Cooperative Study Group of (MR-21) in Tumor].
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):919-27. PubMed ID: 3694000
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
